View Older Stories

Apr 7, 2026 02:34AM Stifel Downgrades Soleno Therapeutics Inc. (SLNO) to Hold

Apr 6, 2026 04:02PM Oppenheimer Downgrades Soleno Therapeutics Inc. (SLNO) to Perform

Apr 6, 2026 02:41PM Neurocrine Bio. (NBIX) PT Raised to $200 at Canaccord

Apr 6, 2026 01:59PM Neurocrine Bio. (NBIX) PT Raised to $220 at Oppenheimer on SLNO deal

Apr 6, 2026 12:27PM Laidlaw Downgrades Soleno Therapeutics Inc. (SLNO) to Hold

Apr 6, 2026 08:45AM Cantor Fitzgerald Downgrades Soleno Therapeutics Inc. (SLNO) to Neutral

Apr 6, 2026 07:11AM Soleno Therapeutics (SLNO) to Resume Trading at 7:30 am

Apr 6, 2026 06:57AM Soleno Therapeutics (SLNO) Halted, News Pending

Apr 6, 2026 05:53AM Neurocrine Biosciences nearing over $2.5B deal for Soleno Therapeutics

Mar 18, 2026 06:03AM Soleno Therapeutics Inc. (SLNO) PT Lowered to $80 at Oppenheimer

Mar 13, 2026 06:28PM Notice to Long-Term Investors of Soleno Therapeutics, Inc. (SLNO): Grabar Law Office Investigates Claims on Your Behalf

Mar 4, 2026 06:43AM Soleno Therapeutics Inc. (SLNO) PT Lowered to $100 at H.C. Wainwright

Feb 25, 2026 04:11PM Soleno Therapeutics, Inc. (SLNO) Tops Q4 EPS by 19c

Jan 20, 2026 06:40AM Soleno Therapeutics Inc. (SLNO) PT Raised to $120 at H.C. Wainwright

Jan 13, 2026 07:04AM Soleno Therapeutics (SLNO) Reiterated at Overweight by Cantor Fitzgerald:Bullish

Jan 13, 2026 04:51AM Soleno Therapeutics Inc. (SLNO) PT Lowered to $107 at Baird

Jan 12, 2026 01:46PM Soleno Therapeutics Inc. (SLNO) PT Lowered to $60 at Wolfe, 'We think the stock reaction reflects the focus around new pt starts'

Jan 12, 2026 08:50AM Stifel on Soleno Therapeutics (SLNO): 'We think SLNO's pre-print is overall solid'

Jan 12, 2026 07:03AM Soleno Therapeutics reports preliminary 2025 revenue of up to $191 million

Jan 5, 2026 08:01AM Soleno Therapeutics publishes VYKAT XR study results in medical journal

Dec 8, 2025 07:32AM Piper Sandler on Biotechnology: 'What Commercial Names to Own in 2026?'

Nov 17, 2025 04:14PM Wolfe Research Starts Soleno Therapeutics Inc. (SLNO) at Outperform

Nov 4, 2025 04:23PM Soleno Therapeutics, Inc. (SLNO) Tops Q3 EPS by 42c

Oct 7, 2025 02:49AM Goldman Sachs Starts Soleno Therapeutics Inc. (SLNO) at Buy

Oct 3, 2025 08:21AM Piper Sandler on Soleno Therapeutics Inc. (SLNO): 'Why We Remain Bullish on VYKAT XR Launch'

Oct 1, 2025 07:24AM Soleno Therapeutics Inc. (SLNO) PT Lowered to $115 at Stifel

Sep 25, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

Sep 25, 2025 04:09AM Baird on Soleno Therapeutics Inc. (SLNO): 'a favorable buying opportunity'

Sep 24, 2025 09:29AM Baird: 'Acadia shares should come out relatively unscathed after the dust settles'

Sep 24, 2025 08:26AM ACAD failure eliminates a competitive threat to Soleno Therapeutics (SLNO) - Oppenheimer

Sep 24, 2025 08:05AM BMO Capital: 'expect ACAD shares to decline'

Sep 24, 2025 07:53AM Wells Fargo on Soleno Therapeutics Inc. (SLNO): 'We Think Shares Should Trade Up at Least +20% on ACAD Failure'

Sep 24, 2025 07:34AM Stifel on Soleno Therapeutics Inc. (SLNO): 'we remain bullish and believe Vykat is well-positioned for significant/sustained growth'

Sep 11, 2025 08:27AM TD Cowen Reiterates Buy on Soleno Therapeutics (SLNO) as Vykat XR Launch Has Exceeds Expectations

Sep 11, 2025 06:59AM Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

Sep 10, 2025 02:03PM Baird Defends Soleno Therapeutics Inc. (SLNO): 'Selloff on Likely Unrelated Patient Death Strengthens Buying Opportunity'

Sep 10, 2025 01:46PM TD Cowen on Soleno Therapeutics Inc. (SLNO): 'Patient Death Not Treatment Related; Vykat XR Safety Continues To Be Consistent'

Sep 10, 2025 12:36PM Soleno Therapeutics reports death of patient taking VYKAT XR drug

Sep 10, 2025 11:25AM Soleno Therapeutics (SLNO) Falls 17%

Aug 21, 2025 11:19AM Piper Sandler on Soleno Therapeutics Inc. (SLNO): 'Strong Launch Execution Could Lift Shares'

Aug 20, 2025 05:28AM Wells Fargo Starts Soleno Therapeutics Inc. (SLNO) at Overweight

Aug 19, 2025 10:24AM Scorpion Capital Still Short Soleno Therapeutics (SLNO)

Aug 19, 2025 06:54AM Cantor Fitzgerald Reiterates Overweight Rating on Soleno Therapeutics Inc. (SLNO)

Aug 19, 2025 05:12AM Baird on Soleno Therapeutics Inc. (SLNO): 'Buyers on pullback following short report'

Aug 18, 2025 09:39AM TD Cowen Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

Aug 18, 2025 06:47AM Soleno Therapeutics Inc. (SLNO) PT Raised to $110 at H.C. Wainwright

Aug 15, 2025 09:21AM Soleno Therapeutics (SLNO) Mentioned as Short at Scorpion Capital

Aug 7, 2025 10:07AM Soleno Therapeutics Inc. (SLNO) PT Raised to $118 at Stifel

Aug 7, 2025 06:56AM Soleno Therapeutics Inc. (SLNO) PT Raised to $106 at Guggenheim

Aug 6, 2025 04:12PM Soleno Therapeutics, Inc. (SLNO) Tops Q2 EPS by 55c

View Older Stories